Nexalin Technology (Nexalin Technology) Operating Cash Flow per Share : $-0.45 (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nexalin Technology Operating Cash Flow per Share?

Nexalin Technology's operating cash flow per share for the three months ended in Mar. 2024 was $-0.10. Nexalin Technology's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.45.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -63.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Nexalin Technology's Operating Cash Flow per Share or its related term are showing as below:

NXL' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -63.6 Med: -63.6 Max: -63.6
Current: -63.6

During the past 4 years, Nexalin Technology's highest 3-Year average Operating Cash Flow per Share Growth Rate was -63.60% per year. The lowest was -63.60% per year. And the median was -63.60% per year.

NXL's 3-Year OCF Growth Rate is ranked worse than
94.16% of 685 companies
in the Medical Devices & Instruments industry
Industry Median: 2.6 vs NXL: -63.60

Nexalin Technology Operating Cash Flow per Share Historical Data

The historical data trend for Nexalin Technology's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nexalin Technology Operating Cash Flow per Share Chart

Nexalin Technology Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

-0.12

-0.22

-0.40

-0.52

Nexalin Technology Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial									-0.18	-0.11	-0.10	-0.14	-0.10

Competitive Comparison of Nexalin Technology's Operating Cash Flow per Share

For the Medical Devices subindustry, Nexalin Technology's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nexalin Technology's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nexalin Technology's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Nexalin Technology's Price-to-Operating-Cash-Flow falls into.

Nexalin Technology Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Nexalin Technology's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-3.835	/	7.357
	=	-0.52

Nexalin Technology's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-0.763	/	7.437
	=	-0.10

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.45

Nexalin Technology Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Nexalin Technology's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Nexalin Technology (Nexalin Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nexalin Technology Inc (NAS:NXL) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

1776 Yorktown, Suite 550, Houston, TX, USA, 77056

Website

https://www.nexalin.com

Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy.

Executives

Marilyn Elson	10 percent owner, officer: Ms. Elson serves as CFO	32 CAMLET COURT, ROSELAND NJ 07068
Rick Morad	director	6331 CHAGRIN RIVER ROAD, BENTLEYVILLE OH 44022
Mark White	director, officer: President/CEO	1776 YORKTOWN STREET, SUITE 550, HOUSTON TX 77056
David Owens	director, officer: Chief Medical Officer	4545 HARRIS TRAIL NW, ATLANTA GA 30327
Alan Kazden	director	3435 CONSUELO DRIVE, CALABASAS CA 91302
Leonard Osser	other: Spouse
Ben Hu	director	7021 EDGERTON ROAD, NORTH ROYALTON OH 44133